Last 12 months
Inside the activity.
1 purchase rows · 23 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 5 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 1 | 1 |
| Apr 2026 | 0 | 3 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2024 Filed Oct 3, 2024 22:46 UTC |
Garde DanielleSVP, Chief People Officer
|
GrantCommon Stock | 814 | $0.00 | $0.00 |
DisclosureSEC source: 0001624794-24-000077 · wk-form4_1727995581.xml · nonDerivative · entry 1 Garde Danielle · CIK 0001949798 · SVP, Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,454 F1 · acquired: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's 2024 Equity and Incentive Compensation Plan. The shares vest ratably over a three-year period on each annual anniversary of the grant. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 22:48 UTC |
Alverson LukeSVP, GC & Secretary
|
Tax withholdingCommon Stock | 549 | $364.56 | $200,143.44 |
DisclosureSEC source: 0001624794-24-000079 · wk-form4_1727995685.xml · nonDerivative · entry 2 Alverson Luke · CIK 0001668461 · SVP, GC & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,572 Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 22:48 UTC |
Alverson LukeSVP, GC & Secretary
|
GrantCommon Stock | 814 | $0.00 | $0.00 |
DisclosureSEC source: 0001624794-24-000079 · wk-form4_1727995685.xml · nonDerivative · entry 1 Alverson Luke · CIK 0001668461 · SVP, GC & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,121 F1 · acquired: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares vest ratably over a three-year period on each annual anniversary of the grant. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 23:32 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
Tax withholdingCommon Stock | 2,970 | $364.56 | $1,082,743.20 |
DisclosureSEC source: 0001624794-24-000080 · wk-form4_1727998343.xml · nonDerivative · entry 2 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,698 Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 23:32 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
GrantCommon Stock | 4,089 | $0.00 | $0.00 |
DisclosureSEC source: 0001624794-24-000080 · wk-form4_1727998343.xml · nonDerivative · entry 1 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,668 F1 · acquired: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares vest ratably over a three-year period on each annual anniversary of the grant. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 22:47 UTC |
Perry James EEVP, CFO
|
Tax withholdingCommon Stock | 1,132 | $364.56 | $412,681.92 |
DisclosureSEC source: 0001624794-24-000078 · wk-form4_1727995632.xml · nonDerivative · entry 2 Perry James E · CIK 0001323684 · EVP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,572 Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 22:47 UTC |
Perry James EEVP, CFO
|
GrantCommon Stock | 1,389 | $0.00 | $0.00 |
DisclosureSEC source: 0001624794-24-000078 · wk-form4_1727995632.xml · nonDerivative · entry 1 Perry James E · CIK 0001323684 · EVP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,704 F1 · acquired: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's 2024 Equity and Incentive Compensation Plan. The shares vest ratably over a three-year period on each annual anniversary of the grant. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 22:45 UTC |
Sullivan DonEVP, Chief Strategy Officer
|
Tax withholdingCommon Stock | 1,249 | $364.56 | $455,335.44 |
DisclosureSEC source: 0001624794-24-000076 · wk-form4_1727995519.xml · nonDerivative · entry 2 Sullivan Don · CIK 0001663176 · EVP, Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,769 Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 22:45 UTC |
Sullivan DonEVP, Chief Strategy Officer
|
GrantCommon Stock | 1,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001624794-24-000076 · wk-form4_1727995519.xml · nonDerivative · entry 1 Sullivan Don · CIK 0001663176 · EVP, Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,018 F1 · acquired: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's 2024 Equity and Incentive Compensation Plan. The shares vest ratably over a three-year period on each annual anniversary of the grant. Read SEC document |
| September 16, 2024 Filed Sep 17, 2024 20:31 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 130 | $344.66 | $44,805.80 |
DisclosureSEC source: 0001624794-24-000074 · wk-form4_1726605096.xml · nonDerivative · entry 7 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 51,579 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023. F6 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $344.37 to $345.24, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| September 16, 2024 Filed Sep 17, 2024 20:31 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 182 | $342.94 | $62,415.08 |
DisclosureSEC source: 0001624794-24-000074 · wk-form4_1726605096.xml · nonDerivative · entry 6 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 51,709 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023. F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $342.65 to $343.41, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| September 16, 2024 Filed Sep 17, 2024 20:31 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 78 | $342.09 | $26,683.02 |
DisclosureSEC source: 0001624794-24-000074 · wk-form4_1726605096.xml · nonDerivative · entry 5 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 51,891 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $341.625 to $342.62, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| September 16, 2024 Filed Sep 17, 2024 20:31 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 367 | $340.57 | $124,989.19 |
DisclosureSEC source: 0001624794-24-000074 · wk-form4_1726605096.xml · nonDerivative · entry 4 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 51,969 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $340.21 to $341.18, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| September 16, 2024 Filed Sep 17, 2024 20:31 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 218 | $339.64 | $74,041.52 |
DisclosureSEC source: 0001624794-24-000074 · wk-form4_1726605096.xml · nonDerivative · entry 3 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 52,336 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $339.01 to $340.01, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| September 16, 2024 Filed Sep 17, 2024 20:31 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 20 | $337.90 | $6,758.00 |
DisclosureSEC source: 0001624794-24-000074 · wk-form4_1726605096.xml · nonDerivative · entry 2 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 52,554 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023. Read SEC document |
| September 16, 2024 Filed Sep 17, 2024 20:31 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 5 | $336.28 | $1,681.40 |
DisclosureSEC source: 0001624794-24-000074 · wk-form4_1726605096.xml · nonDerivative · entry 1 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 52,574 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023. Read SEC document |
| August 15, 2024 Filed Aug 16, 2024 20:47 UTC |
Griffin BobbyDirector
|
GrantCommon Stock | 360 | $0.00 | $0.00 |
DisclosureSEC source: 0001624794-24-000073 · wk-form4_1723841259.xml · nonDerivative · entry 1 Griffin Bobby · CIK 0001896568 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,448 F1 · price: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares cliff vest on the earlier of (i) the first anniversary of the grant or (ii) the date of the issuer's 2025 annual meeting of shareholders. Read SEC document |
| August 15, 2024 Filed Aug 16, 2024 16:42 UTC |
Sweezey Jay KentDirector
|
GrantCommon Stock | 360 | $0.00 | $0.00 |
DisclosureSEC source: 0001624794-24-000066 · wk-form4_1723840961.xml · nonDerivative · entry 1 Sweezey Jay Kent · CIK 0001691674 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,686 F1 · price: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares cliff vest on the earlier of (i) the first anniversary of the grant or (ii) the date of the issuer's 2025 annual meeting of shareholders. Read SEC document |
| August 15, 2024 Filed Aug 16, 2024 20:45 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 125 | $314.51 | $39,313.75 |
DisclosureSEC source: 0001624794-24-000069 · wk-form4_1723841125.xml · nonDerivative · entry 4 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 52,579 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023. F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $314.15 to $314.81, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 15, 2024 Filed Aug 16, 2024 20:45 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 553 | $313.39 | $173,304.67 |
DisclosureSEC source: 0001624794-24-000069 · wk-form4_1723841125.xml · nonDerivative · entry 3 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 52,704 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $313.07 to $313.97, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 15, 2024 Filed Aug 16, 2024 20:45 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 291 | $312.69 | $90,992.79 |
DisclosureSEC source: 0001624794-24-000069 · wk-form4_1723841125.xml · nonDerivative · entry 2 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,257 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $312.06 to $313.02, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 15, 2024 Filed Aug 16, 2024 20:45 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 31 | $311.28 | $9,649.68 |
DisclosureSEC source: 0001624794-24-000069 · wk-form4_1723841125.xml · nonDerivative · entry 1 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,548 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $310.81 to $311.75, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 15, 2024 Filed Aug 16, 2024 16:43 UTC |
Swartz Robert MDirector
|
GrantCommon Stock | 360 | $0.00 | $0.00 |
DisclosureSEC source: 0001624794-24-000067 · wk-form4_1723841016.xml · nonDerivative · entry 1 Swartz Robert M · CIK 0001413221 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,919 F1 · price: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares cliff vest on the earlier of (i) the first anniversary of the grant or (ii) the date of the issuer's 2025 annual meeting of shareholders. Read SEC document |
| August 15, 2024 Filed Aug 16, 2024 20:46 UTC |
GAMBRELL MICHAEL RDirector
|
GrantCommon Stock | 360 | $0.00 | $0.00 |
DisclosureSEC source: 0001624794-24-000071 · wk-form4_1723841191.xml · nonDerivative · entry 1 GAMBRELL MICHAEL R · CIK 0001277031 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,418 F1 · price: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares cliff vest on the earlier of (i) the first anniversary of the grant or (ii) the date of the issuer's 2025 annual meeting of shareholders. Read SEC document |
| August 15, 2024 Filed Aug 16, 2024 20:41 UTC |
Ash Darron KDirector
|
GrantCommon Stock | 360 | $0.00 | $0.00 |
DisclosureSEC source: 0001624794-24-000065 · wk-form4_1723840876.xml · nonDerivative · entry 1 Ash Darron K · CIK 0001519706 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 360 F1 · price: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares cliff vest on the earlier of (i) the first anniversary of the grant or (ii) the date of the issuer's 2025 annual meeting of shareholders. Read SEC document |
| August 15, 2024 Filed Aug 16, 2024 20:47 UTC |
JOHNSTON TERRY LDirector
|
GrantCommon Stock | 360 | $0.00 | $0.00 |
DisclosureSEC source: 0001624794-24-000072 · wk-form4_1723841222.xml · nonDerivative · entry 1 JOHNSTON TERRY L · CIK 0001565364 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,492 F1 · price: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares cliff vest on the earlier of (i) the first anniversary of the grant or (ii) the date of the issuer's 2025 annual meeting of shareholders. Read SEC document |
| August 15, 2024 Filed Aug 16, 2024 20:46 UTC |
LIVINGSTONE LINDA A.Director
|
GrantCommon Stock | 360 | $0.00 | $0.00 |
DisclosureSEC source: 0001624794-24-000070 · wk-form4_1723841157.xml · nonDerivative · entry 1 LIVINGSTONE LINDA A. · CIK 0001652531 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,918 F1 · price: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares cliff vest on the earlier of (i) the first anniversary of the grant or (ii) the date of the issuer's 2025 annual meeting of shareholders. Read SEC document |
| August 15, 2024 Filed Aug 16, 2024 20:44 UTC |
Motsenbocker AnneDirector
|
GrantCommon Stock | 360 | $0.00 | $0.00 |
DisclosureSEC source: 0001624794-24-000068 · wk-form4_1723841076.xml · nonDerivative · entry 1 Motsenbocker Anne · CIK 0001904253 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,750 F1 · price: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares cliff vest on the earlier of (i) the first anniversary of the grant or (ii) the date of the issuer's 2025 annual meeting of shareholders. Read SEC document |
| July 15, 2024 Filed Jul 16, 2024 20:39 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 197 | $287.76 | $56,688.72 |
DisclosureSEC source: 0001624794-24-000052 · wk-form4_1721162359.xml · nonDerivative · entry 8 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,579 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023. F8 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $287.54 to $288.09, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 15, 2024 Filed Jul 16, 2024 20:39 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 340 | $287.13 | $97,624.20 |
DisclosureSEC source: 0001624794-24-000052 · wk-form4_1721162359.xml · nonDerivative · entry 7 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,776 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023. F7 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $286.49 to $287.49, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 15, 2024 Filed Jul 16, 2024 20:39 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 160 | $285.54 | $45,686.40 |
DisclosureSEC source: 0001624794-24-000052 · wk-form4_1721162359.xml · nonDerivative · entry 6 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,116 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023. F6 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $285.05 to $286.05, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 15, 2024 Filed Jul 16, 2024 20:39 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 162 | $284.39 | $46,071.18 |
DisclosureSEC source: 0001624794-24-000052 · wk-form4_1721162359.xml · nonDerivative · entry 5 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,276 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023. F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $283.99 to $284.94, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 15, 2024 Filed Jul 16, 2024 20:39 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 51 | $283.30 | $14,448.30 |
DisclosureSEC source: 0001624794-24-000052 · wk-form4_1721162359.xml · nonDerivative · entry 4 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,438 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $282.94 to $283.75, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 15, 2024 Filed Jul 16, 2024 20:39 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 40 | $281.85 | $11,274.00 |
DisclosureSEC source: 0001624794-24-000052 · wk-form4_1721162359.xml · nonDerivative · entry 3 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,489 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $281.50 to $282.30, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 15, 2024 Filed Jul 16, 2024 20:39 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 40 | $280.23 | $11,209.20 |
DisclosureSEC source: 0001624794-24-000052 · wk-form4_1721162359.xml · nonDerivative · entry 2 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,529 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $280.16 to $280.28, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 15, 2024 Filed Jul 16, 2024 20:39 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 10 | $278.76 | $2,787.60 |
DisclosureSEC source: 0001624794-24-000052 · wk-form4_1721162359.xml · nonDerivative · entry 1 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,569 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023. Read SEC document |
| June 17, 2024 Filed Jun 18, 2024 20:28 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 24 | $268.67 | $6,448.08 |
DisclosureSEC source: 0001624794-24-000051 · wk-form4_1718742512.xml · nonDerivative · entry 6 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,579 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023. Read SEC document |
| June 17, 2024 Filed Jun 18, 2024 20:28 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 181 | $267.42 | $48,403.02 |
DisclosureSEC source: 0001624794-24-000051 · wk-form4_1718742512.xml · nonDerivative · entry 5 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,603 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023. F6 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $267.115 to $267.81, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| June 17, 2024 Filed Jun 18, 2024 20:28 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 325 | $266.46 | $86,599.50 |
DisclosureSEC source: 0001624794-24-000051 · wk-form4_1718742512.xml · nonDerivative · entry 4 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,784 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023. F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $266.05 to $266.985, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| June 17, 2024 Filed Jun 18, 2024 20:28 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 88 | $265.18 | $23,335.84 |
DisclosureSEC source: 0001624794-24-000051 · wk-form4_1718742512.xml · nonDerivative · entry 3 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 55,109 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $264.76 to $265.67, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| June 17, 2024 Filed Jun 18, 2024 20:28 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 250 | $264.22 | $66,055.00 |
DisclosureSEC source: 0001624794-24-000051 · wk-form4_1718742512.xml · nonDerivative · entry 2 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 55,197 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $263.71 to $264.46, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| June 17, 2024 Filed Jun 18, 2024 20:28 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 132 | $263.16 | $34,737.12 |
DisclosureSEC source: 0001624794-24-000051 · wk-form4_1718742512.xml · nonDerivative · entry 1 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 55,447 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $262.56 to $263.56, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 30, 2024 Filed May 30, 2024 23:38 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 121 | $258.71 | $31,303.91 |
DisclosureSEC source: 0001624794-24-000038 · wk-form4_1717112316.xml · nonDerivative · entry 4 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 55,579 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023. F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $258.46 to $259.06, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 30, 2024 Filed May 30, 2024 23:38 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 378 | $257.77 | $97,437.06 |
DisclosureSEC source: 0001624794-24-000038 · wk-form4_1717112316.xml · nonDerivative · entry 3 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 55,700 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $257.38 to $258.23, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 30, 2024 Filed May 30, 2024 23:38 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 250 | $257.03 | $64,257.50 |
DisclosureSEC source: 0001624794-24-000038 · wk-form4_1717112316.xml · nonDerivative · entry 2 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,078 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $256.31 to $257.30, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 30, 2024 Filed May 30, 2024 23:38 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 251 | $255.52 | $64,135.52 |
DisclosureSEC source: 0001624794-24-000038 · wk-form4_1717112316.xml · nonDerivative · entry 1 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,328 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $255.21 to $256.205, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 29, 2024 Filed May 30, 2024 23:42 UTC |
UNDERWOOD JEFFSVP, GM Contractor Solutions
|
GrantPerformance Rights · Derivative | 954 | $0.00 | $0.00 |
DisclosureSEC source: 0001624794-24-000042 · wk-form4_1717112514.xml · derivative · entry 1 UNDERWOOD JEFF · CIK 0002017190 · SVP, GM Contractor Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 954 Underlying: Common Stock · 954 shares Expires not disclosed F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024 and ending on March 31, 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F1 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024 and ending on March 31, 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F1 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024 and ending on March 31, 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Read SEC document |
| May 29, 2024 Filed May 30, 2024 23:35 UTC |
Garde DanielleSVP, Chief People Officer
|
GrantPerformance Rights · Derivative | 1,006 | $0.00 | $0.00 |
DisclosureSEC source: 0001624794-24-000036 · wk-form4_1717112139.xml · derivative · entry 1 Garde Danielle · CIK 0001949798 · SVP, Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,006 Underlying: Common Stock · 1,006 shares Expires not disclosed F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024 and ending on March 31, 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F1 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024 and ending on March 31, 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F1 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024 and ending on March 31, 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Read SEC document |
| May 29, 2024 Filed May 30, 2024 23:39 UTC |
Alverson LukeSVP, GC & Secretary
|
GrantPerformance Rights · Derivative | 1,093 | $0.00 | $0.00 |
DisclosureSEC source: 0001624794-24-000039 · wk-form4_1717112368.xml · derivative · entry 1 Alverson Luke · CIK 0001668461 · SVP, GC & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,093 Underlying: Common Stock · 1,093 shares Expires not disclosed F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024 and ending on March 31, 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F1 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024 and ending on March 31, 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F1 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024 and ending on March 31, 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Read SEC document |
| May 29, 2024 Filed May 30, 2024 23:38 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
GrantPerformance Rights · Derivative | 8,236 | $0.00 | $0.00 |
DisclosureSEC source: 0001624794-24-000038 · wk-form4_1717112316.xml · derivative · entry 7 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,236 Underlying: Common Stock · 8,236 shares Expires not disclosed F6 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024 and ending on March 31, 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F6 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024 and ending on March 31, 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F6 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024 and ending on March 31, 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.